• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卷曲螺旋结构域 B 表面多肽对嘌呤霉素氨基核苷肾病大鼠的肾脏保护作用。

Renal protective effects of helix B surface polypeptide in rats with puromycin aminonucleoside nephropathy.

机构信息

Division of Nephrology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.

出版信息

Ren Fail. 2024 Dec;46(2):2394637. doi: 10.1080/0886022X.2024.2394637. Epub 2024 Aug 27.

DOI:10.1080/0886022X.2024.2394637
PMID:39189638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11351356/
Abstract

BACKGROUND

Recent studies have reported that helix B surface polypeptide (HBSP), an erythropoietin derivative, exhibits strong tissue protective effects, independent of erythropoietic effects, in a renal ischemia-reperfusion (IR) injury model. Meanwhile, the transforming growth factor-β (TGF-β) superfamily member glial cell line-derived neurotrophic factor (GDNF) demonstrated protective effect on podocytes . Using a rat puromycin aminonucleoside nephropathy (PAN) model, this study observed the renal protective effect of HBSP and investigated its renal protective effect on podocytes and mechanism related to GDNF.

METHODS

Rats nephropathy model was induced by injection of 60 mg/kg of PAN the tail vein. Rats in the PAN + HBSP group were injected intraperitoneally with HBSP (8 nmol/kg) 4 h before the model was induced, followed by intraperitoneal injections of HBSP once every 24 h for 7 consecutive days. The 24-hour urinary protein level was measured once every other day, and blood and renal tissue samples were collected on the 7th day for the examination of renal function, complete blood count, renal pathological changes and the expression levels of GDNF.

RESULTS

Compared with the control group, the PAN nephropathy rat model showed a large amount of urinary protein. The pathological manifestations were mainly extensive fusion and disappearance of foot processes, along with vacuolar degeneration of podocytes and their separation from the glomerular basement membrane. GDNF expression was upregulated. Compared with the PAN + vehicle group, the PAN + HBSP group showed decreased urinary protein ( < 0.05). Pathological examination revealed ameliorated glomerular injury and vacuolar degeneration of podocytes. The expression of GDNF in the PAN nephropathy group was increased, when compared with the control group. The greatest expression of GDNF observed in the PAN + HBSP group ( < 0.05).

CONCLUSIONS

The expression of GDNF in the kidney of PAN rat model was increased. HBSP reduced urinary protein, ameliorated pathological changes in renal podocytes, increased the expression of GDNF in the PAN rat model. HBSP is likely to exert its protective effects on podocytes through upregulation of GDNF expression.

摘要

背景

最近的研究报告称,红细胞生成素衍生物螺旋 B 表面多肽(HBSP)在肾缺血再灌注(IR)损伤模型中具有很强的组织保护作用,且不依赖于红细胞生成作用。同时,神经胶质细胞衍生神经营养因子(GDNF)是转化生长因子-β(TGF-β)超家族成员,对足细胞具有保护作用。本研究采用大鼠嘌呤霉素氨基核苷肾病(PAN)模型,观察 HBSP 的肾保护作用,并探讨其对足细胞的保护作用及其与 GDNF 相关的机制。

方法

通过尾静脉注射 60mg/kg 的嘌呤霉素氨基核苷诱导大鼠肾病模型。在诱导模型前 4 小时,PAN+HBSP 组大鼠腹腔内注射 HBSP(8nmol/kg),随后每 24 小时腹腔内注射一次,连续 7 天。每隔一天测量一次 24 小时尿蛋白水平,第 7 天采集血和肾组织样本,检查肾功能、全血细胞计数、肾组织病理学变化和 GDNF 表达水平。

结果

与对照组相比,PAN 肾病大鼠模型的尿蛋白大量增加。病理表现主要为广泛融合和足突消失,同时伴有足细胞空泡变性和与肾小球基底膜分离。GDNF 表达上调。与 PAN+载体组相比,PAN+HBSP 组尿蛋白减少(<0.05)。病理检查显示肾小球损伤和足突细胞空泡变性得到改善。与对照组相比,PAN 肾病组 GDNF 的表达增加。在 PAN+HBSP 组观察到 GDNF 的表达最高(<0.05)。

结论

PAN 大鼠模型肾组织中 GDNF 的表达增加。HBSP 减少尿蛋白,改善肾足突细胞的病理变化,增加 PAN 大鼠模型中 GDNF 的表达。HBSP 可能通过上调 GDNF 的表达发挥对足细胞的保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f654/11351356/eee1cdd3d49b/IRNF_A_2394637_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f654/11351356/787b9b910ed0/IRNF_A_2394637_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f654/11351356/ac2d41b4d304/IRNF_A_2394637_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f654/11351356/eee1cdd3d49b/IRNF_A_2394637_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f654/11351356/787b9b910ed0/IRNF_A_2394637_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f654/11351356/ac2d41b4d304/IRNF_A_2394637_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f654/11351356/eee1cdd3d49b/IRNF_A_2394637_F0003_B.jpg

相似文献

1
Renal protective effects of helix B surface polypeptide in rats with puromycin aminonucleoside nephropathy.卷曲螺旋结构域 B 表面多肽对嘌呤霉素氨基核苷肾病大鼠的肾脏保护作用。
Ren Fail. 2024 Dec;46(2):2394637. doi: 10.1080/0886022X.2024.2394637. Epub 2024 Aug 27.
2
[Renal expression of RANK-RANKL in a rat model of puromycin aminonucleoside nephropathy].嘌呤霉素氨基核苷肾病大鼠模型中RANK-RANKL的肾脏表达
Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jan;34(1):65-9.
3
Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats.1,25-二羟维生素 D 通过调节转化生长因子-β1/骨形态发生蛋白-7 信号通路抑制嘌呤霉素氨基核苷肾病大鼠足细胞损伤。
Clin Exp Pharmacol Physiol. 2009 Jul;36(7):682-9. doi: 10.1111/j.1440-1681.2008.05133.x.
4
[Differential expressions of miRNAs in kidney in puromycin aminonucleoside nephropathy model and intervened effects of Leizhi capsule].[嘌呤霉素氨基核苷肾病模型大鼠肾脏中微小RNA的差异表达及雷蛭胶囊的干预作用]
Zhongguo Zhong Yao Za Zhi. 2013 Jan;38(1):81-90.
5
Quantitative analysis of markers of podocyte injury in the rat puromycin aminonucleoside nephropathy model.嘌呤霉素氨基核苷肾病大鼠模型中足细胞损伤标志物的定量分析
Exp Toxicol Pathol. 2015 Feb;67(2):171-7. doi: 10.1016/j.etp.2014.11.007. Epub 2014 Dec 4.
6
[Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].[骨间充质干细胞移植修复嘌呤霉素氨基核苷诱导肾病大鼠的肾小球足细胞]
Zhongguo Dang Dai Er Ke Za Zhi. 2010 Jun;12(6):483-7.
7
Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.托伐普坦,一种选择性口服血管加压素V2受体拮抗剂,可改善嘌呤霉素氨基核苷肾病大鼠的足细胞损伤。
Clin Exp Nephrol. 2009 Oct;13(5):438-446. doi: 10.1007/s10157-009-0196-0. Epub 2009 May 19.
8
Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease.尿纤维蛋白溶酶原血症与初发肾小球疾病中的足细胞损伤、水肿和肾功能障碍有关。
FASEB J. 2020 Dec;34(12):16191-16204. doi: 10.1096/fj.202000413R. Epub 2020 Oct 18.
9
Hirudin attenuates puromycin aminonucleoside-induced glomerular podocyte injury by inhibiting MAPK-mediated endoplasmic reticulum stress.水蛭素通过抑制 MAPK 介导的内质网应激减轻嘌呤霉素氨基核苷诱导的肾小球足细胞损伤。
Drug Dev Res. 2022 Jun;83(4):1047-1056. doi: 10.1002/ddr.21932. Epub 2022 Mar 11.
10
Glial cell line-derived neurotrophic factor and its receptor ret is a novel ligand-receptor complex critical for survival response during podocyte injury.胶质细胞系源性神经营养因子及其受体Ret是一种新型配体-受体复合物,对足细胞损伤时的存活反应至关重要。
J Am Soc Nephrol. 2006 Jun;17(6):1543-52. doi: 10.1681/ASN.2005080835. Epub 2006 May 3.

本文引用的文献

1
Corrigendum: HBSP improves kidney ischemia-reperfusion injury and promotes repair in properdin deficient mice via enhancing phagocytosis of tubular epithelial cells.勘误:HBSP通过增强肾小管上皮细胞的吞噬作用改善补体因子D缺乏小鼠的肾脏缺血再灌注损伤并促进修复。
Front Immunol. 2023 Jun 29;14:1242436. doi: 10.3389/fimmu.2023.1242436. eCollection 2023.
2
Quantitative analysis of markers of podocyte injury in the rat puromycin aminonucleoside nephropathy model.嘌呤霉素氨基核苷肾病大鼠模型中足细胞损伤标志物的定量分析
Exp Toxicol Pathol. 2015 Feb;67(2):171-7. doi: 10.1016/j.etp.2014.11.007. Epub 2014 Dec 4.
3
A novel proteolysis-resistant cyclic helix B peptide ameliorates kidney ischemia reperfusion injury.
一种新型抗蛋白水解的环状螺旋B肽可改善肾脏缺血再灌注损伤。
Biochim Biophys Acta. 2014 Nov;1842(11):2306-17. doi: 10.1016/j.bbadis.2014.09.001. Epub 2014 Sep 9.
4
Remote conditioning or erythropoietin before surgery primes kidneys to clear ischemia-reperfusion-damaged cells: a renoprotective mechanism?手术前的远程调节或促红细胞生成素使肾脏预先清除缺血再灌注损伤细胞:一种肾脏保护机制?
Am J Physiol Renal Physiol. 2014 Apr 15;306(8):F873-84. doi: 10.1152/ajprenal.00576.2013. Epub 2014 Feb 12.
5
[Renal expression of RANK-RANKL in a rat model of puromycin aminonucleoside nephropathy].嘌呤霉素氨基核苷肾病大鼠模型中RANK-RANKL的肾脏表达
Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jan;34(1):65-9.
6
Protective effects of HBSP on ischemia reperfusion and cyclosporine a induced renal injury.血红蛋白结合珠蛋白对缺血再灌注及环孢素A诱导的肾损伤的保护作用。
Clin Dev Immunol. 2013;2013:758159. doi: 10.1155/2013/758159. Epub 2013 Oct 27.
7
Repeated systemic administration of human adipose-derived stem cells attenuates overt diabetic nephropathy in rats.反复给予人脂肪来源干细胞可减轻大鼠显性糖尿病肾病。
Stem Cells Dev. 2013 Dec 1;22(23):3074-86. doi: 10.1089/scd.2013.0142. Epub 2013 Aug 21.
8
Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and neutrophil gelatinase-associated lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trial.心脏手术患者中,促红细胞生成素与安慰剂预防对比可减少急性肾损伤及中性粒细胞明胶酶相关脂质运载蛋白:一项随机、双盲对照试验
BMC Nephrol. 2013 Jul 5;14:136. doi: 10.1186/1471-2369-14-136.
9
Erythropoietin receptor (EpoR) agonism is used to treat a wide range of disease.促红细胞生成素受体(EpoR)激动剂被用于治疗广泛的疾病。
Mol Med. 2013 Apr 30;19(1):62-4. doi: 10.2119/molmed.2013.00025.
10
The role of the podocyte in albumin filtration.足细胞在白蛋白滤过中的作用。
Nat Rev Nephrol. 2013 Jun;9(6):328-36. doi: 10.1038/nrneph.2013.78. Epub 2013 Apr 23.